Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Phizackerley

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Drug and Therapeutics Bulletin|April 27, 2022
From info-desert to info-demic: the role of independent drug bulletinsDavid Phizackerley, James A Cave
Drug and Therapeutics Bulletin|June 22, 2020
Virtual revolution?James A Cave, David Phizackerley
Drug and Therapeutics Bulletin|November 7, 2020
What price Priadel?David Phizackerley, James A Cave
Drug and Therapeutics Bulletin|April 28, 2023
What does <i>DTB</i> stand for?James A Cave, David Phizackerley
Drug and Therapeutics Bulletin|October 27, 2018
Conditional approval: who knows?Henry Fok, Khong Teck, David Phizackerley
BMJ (Clinical Research Ed.)|November 13, 2023
Better prescribing for safer, more effective healthcareDavid Phizackerley, Neil Chanchlani, Fraz Mir
Drug and Therapeutics Bulletin|August 24, 2021
Desogestrel POM to P: for the few not the many?David Phizackerley, Joanna Girling, James A Cave
Health Policy (Amsterdam, Netherlands)|January 12, 2017
Drug information by public health and regulatory institutions: Results of an 8-country survey in EuropeGiulio Formoso, Maria Font-Pous, Wolf-Dieter Ludwig, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Drug and Therapeutics Bulletin|April 27, 2022
From info-desert to info-demic: the role of independent drug bulletinsDavid Phizackerley, James A Cave
Drug and Therapeutics Bulletin|June 22, 2020
Virtual revolution?James A Cave, David Phizackerley
Drug and Therapeutics Bulletin|November 7, 2020
What price Priadel?David Phizackerley, James A Cave
Drug and Therapeutics Bulletin|April 28, 2023
What does <i>DTB</i> stand for?James A Cave, David Phizackerley
Drug and Therapeutics Bulletin|October 27, 2018
Conditional approval: who knows?Henry Fok, Khong Teck, David Phizackerley
BMJ (Clinical Research Ed.)|November 13, 2023
Better prescribing for safer, more effective healthcareDavid Phizackerley, Neil Chanchlani, Fraz Mir
Drug and Therapeutics Bulletin|August 24, 2021
Desogestrel POM to P: for the few not the many?David Phizackerley, Joanna Girling, James A Cave
Health Policy (Amsterdam, Netherlands)|January 12, 2017
Drug information by public health and regulatory institutions: Results of an 8-country survey in EuropeGiulio Formoso, Maria Font-Pous, Wolf-Dieter Ludwig, et al.
Pageof 4